Trials / Completed
CompletedNCT04726098
Low or High Dose of Dexamethasone in Patients With Respiratory Failure by COVID-19
Efficacy of Low or High Dose of Dexamethasone in Patients With Respiratory Failure by COVID-19
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 198 (actual)
- Sponsor
- Manuel Taboada Muñiz · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
After RECOVERY trial publication, low dose (6 mg dexamethasone for 10 days) was recommended as the usual care treatment in hospitalized patients with respiratory failure by COVID-19 needing oxygen therapy. RECOVERY trial showed how the use of dexamethasone 6 mg / day for ten days compared to standard treatment without the use of corticosteroids in hospitalized patients reduced mortality at 28 days (22.9% with dexamethasone vs 25.7% without dexamethasone). In the dexamethasone group, the incidence of mortality was lower than standard treatment in patients with hypoxia and the need for mechanical ventilation (29.3% with dexamethasone vs 41.4% without dexamethasone), in patients admitted to the hospital ward with a need for oxygen therapy (23.3% with dexamethasone vs 26.2% without dexamethasone), but they did not find differences between those admitted patients who did not need oxygen therapy. There are two other studies (DEXA-COVID-19 and CoDEX) where they observed benefits of the use of dexamethasone 20 mg / day 5 days, and 10 mg / day 5 days (total 10 days) in patients admitted for respiratory distress syndrome (ARDS) and COVID-19. At present, it is unclear what dose of dexamethasone is most beneficial in patients with COVID-19 and respiratory failure.
Detailed description
Objective: The investigators aim to assess the efficacy of high dose of dexamethasone (20 mg / day 5 days, and 10 mg/day 5 days) versus low dose of dexamethasone (6 mg/day 10 days) in patients with respiratory failure by COVID-19.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexamethasone high dose | High doses: dexamethasone 20 mg/day 5 days + 10 mg/day 5 days (total 10 days) |
| DRUG | Dexamethasone low dose | Low doses: dexamethasone 6 mg/day 10 days. |
Timeline
- Start date
- 2021-01-15
- Primary completion
- 2021-08-31
- Completion
- 2021-08-31
- First posted
- 2021-01-27
- Last updated
- 2021-10-20
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT04726098. Inclusion in this directory is not an endorsement.